C. Sue Richards

6.5k citations

45 papers · 3.8k indexed · 4 hit papers · h-index 22

Genetics top 0.5%
Molecular Biology top 5%
Cancer Research top 5%
Cellular and Molecular Neuroscience top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Sherri J. Bale Michael S. Watson Wayne W. Grody David T. Miller Wendy K. Chung Christa Lese Martin Teri E. Klein Kent D. McKelvey
Topics: Genomics and Rare Diseases (13 papers)Genetic Neurodegenerative Diseases (10 papers)Genetic factors in colorectal cancer (8 papers)
Cited by: Genetics Cancer Research Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences Nature Genetics Neurology
Partner nations: United States Canada Poland

In The Last Decade

C. Sue Richards

45 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

2016 1.0k citations Sarah S. Kalia, Sherri J. Bale et al. Genetics in Medicine profile →
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007

2008 569 citations C. Sue Richards, Sherri J. Bale et al. Genetics in Medicine profile →
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

2021 302 citations David T. Miller, Kristy Lee et al. Genetics in Medicine profile →
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

2023 157 citations David T. Miller, Kristy Lee et al. Genetics in Medicine profile →

Peers

Countries citing papers authored by C. Sue Richards

Since Specialization

Citations

This map shows the geographic impact of C. Sue Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Sue Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Sue Richards more than expected).

Fields of papers citing papers by C. Sue Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Sue Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Sue Richards. The network helps show where C. Sue Richards may publish in the future.

Co-authorship network of co-authors of C. Sue Richards

This figure shows the co-authorship network connecting the top 25 collaborators of C. Sue Richards. A scholar is included among the top collaborators of C. Sue Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Sue Richards. C. Sue Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) 2025 ·Genetics in Medicine ·Kristy Lee,Noura S. Abul‐Husn,Laura M. Amendola,Kyle B. Brothers,Wendy K. Chung,Michael H. Gollob,Allan Gordon,Steven M. Harrison,Ray E. Hershberger,Marilyn M. Li,(unknown),C. Sue Richards,Andrew B. Stergachis,Douglas R. Stewart,Christa Lese Martin,David T. Miller	6
2	Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG) 2024 ·Genetics in Medicine ·Allan Gordon,Kristy Lee,Noura S. Abul‐Husn,Laura M. Amendola,Kyle B. Brothers,Wendy K. Chung,Michael H. Gollob,Steven M. Harrison,(unknown),C. Sue Richards,Douglas R. Stewart,Christa Lese Martin,David T. Miller	8
3	An Educational Assessment of Evidence Used for Variant Classification 2022 ·Journal of Molecular Diagnostics ·Elaine Lyon,Robyn Temple‐Smolkin,Madhuri Hegde,Julie M. Gastier‐Foster,Glenn E. Palomaki,C. Sue Richards	4
4	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) 2021 ·Genetics in Medicine ·David T. Miller,Kristy Lee,Allan Gordon,Laura M. Amendola,(unknown),Sherri J. Bale,Wendy K. Chung,Michael H. Gollob,Steven M. Harrison,Gail E. Herman,Ray E. Hershberger,Teri E. Klein,Kent D. McKelvey,C. Sue Richards,Christopher N. Vlangos,Douglas R. Stewart,Michael S. Watson,Christa Lese Martin	142
5	A case for expanding carrier testing to include actionable X‐linked disorders 2018 ·Clinical Case Reports ·Alan F. Rope,Tia L. Kauffman,(unknown),Laura M. Amendola,Sumit Punj,Yassmine Akkari,(unknown),James V. Davis,Jennifer L. Schneider,Jacob A. Reiss,(unknown),Carmit K. McMullen,Deborah A. Nickerson,C. Sue Richards,Gail P. Jarvik,Benjamin S. Wilfond,Katrina A.B. Goddard	2
6	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomicsbreakdown → 2016 ·Genetics in Medicine ·Sarah S. Kalia,(unknown),Sherri J. Bale,Wendy K. Chung,Christine M. Eng,James P. Evans,Gail E. Herman,Sophia B. Hufnagel,Teri E. Klein,Bruce R. Korf,Kent D. McKelvey,Kelly E. Ormond,C. Sue Richards,Christopher N. Vlangos,Michael S. Watson,Christa Lese Martin,David T. Miller	1023
7	Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys 2014 ·Genetics in Medicine ·Elaine Lyon,Iris Schrijver,Karen E. Weck,Andrea Ferreira‐Gonzalez,C. Sue Richards,Glenn E. Palomaki	9
8	Risk categorization for oversight of laboratory-developed tests for inherited conditions 2013 ·Genetics in Medicine ·Kristin G. Monaghan,Judith Benkendorf,Athena M. Cherry,Susan J. Gross,C. Sue Richards,V. Reid Sutton,Michael S. Watson	11
9	Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey 2012 ·Genetics in Medicine ·Glenn E. Palomaki,C. Sue Richards	13
10	Development of genomic reference materials for Huntington disease genetic testing 2007 ·Genetics in Medicine ·Lisa V. Kalman,Monique Johnson,Jeanne C. Beck,Elizabeth Berry‐Kravis,Arlene Buller,Brett Casey,Gerald L. Feldman,(unknown),John P. Jakupciak,Samantha Maragh,Karla J. Matteson,Kasinathan Muralidharan,(unknown),Elizabeth M. Rohlfs,Frederick V. Schaefer,(unknown),Elaine Spector,C. Sue Richards	16
11	Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories 2005 ·Genetics in Medicine ·Elaine Spector,Wayne W. Grody,(unknown),Glenn E. Palomaki,Daniel B. Bellissimo,Daynna J. Wolff,Linda Bradley,Thomas W. Prior,Gerald L. Feldman,Bradley W. Popovich,Michael S. Watson,C. Sue Richards	33
12	Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel 2004 ·Genetics in Medicine ·Michael S. Watson,Garry R. Cutting,Robert J. Desnick,Deborah A. Driscoll,K. Klinger,Michael T. Mennuti,Glenn E. Palomaki,Bradley W. Popovich,Victoria M. Pratt,Elizabeth M. Rohlfs,Charles M. Strom,C. Sue Richards,David R. Witt,Wayne W. Grody	315
13	Analytic validity of cystic fibrosis testing: A preliminary estimate 2003 ·Genetics in Medicine ·Glenn E. Palomaki,Linda Bradley,C. Sue Richards,James E. Haddow	19
14	Diagnostic DNA Testing for X-Linked Ocular Albinism ( OA1 ) with a Hierarchical Mutation Screening Protocol 2002 ·Genetic Testing ·Madhuri Hegde,Richard A. Lewis,C. Sue Richards	7
15	Detection of Sequence Variations in the Adenomatous Polyposis Coli ( APC ) Gene Using Denaturing High-Performance Liquid Chromatography 2001 ·Genetic Testing ·Guohao Wu,Wei Wu,Madhuri Hegde,(unknown),Belinda Chong,Donald R. Love,Li Su,Patrick M. Lynch,Karen Snow,C. Sue Richards	30
16	Ashkenazi Jewish Population Frequency of the Bloom Syndrome Gene 2281Δ6ins7 Mutation 1999 ·Genetic Testing ·Benjamin B. Roa,(unknown),C. Sue Richards	26
17	Estimated Contribution of Known Ataxia Genes in Ataxia Patients Undergoing DNA Testing 1997 ·Genetic Testing ·Preethi H. Gunaratne,C. Sue Richards	3
18	Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews 1996 ·Human Mutation ·J Demarchi,C. Thomas Caskey,C. Sue Richards	22
19	Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease 1996 ·American Journal of Medical Genetics ·Raye Lynn Alford,Tetsuo Ashizawa,Joseph Jankovic,C. Thomas Caskey,C. Sue Richards	7
20	Differentiation of schistosomes by species, strain, and sex by using cloned DNA markers. 1984 ·Proceedings of the National Academy of Sciences ·Thomas F. McCutchan,Andrew J.G. Simpson,(unknown),Alan Sher,T E Nash,Fred A. Lewis,C. Sue Richards	72

About C. Sue Richards

C. Sue Richards is a scholar working on Genetics, Cellular and Molecular Neuroscience and Internal Medicine, having authored 45 papers that have together received 3.8k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (13 papers), Genetic Neurodegenerative Diseases (10 papers) and Genetic factors in colorectal cancer (8 papers). The work is most often cited by research in Genetics (2.1k citations), Cancer Research (499 citations) and Cellular and Molecular Neuroscience (460 citations). C. Sue Richards has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Sherri J. Bale, Michael S. Watson, Wayne W. Grody, David T. Miller, Wendy K. Chung, Christa Lese Martin, Teri E. Klein, Kent D. McKelvey, Gail E. Herman and Christopher N. Vlangos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact